Alanine Aminotransferase
Alanine Aminotransferase - Related Videos
06:00
Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
0 Views •
2025
We present a laparoscopic technique for anatomic S7+S8d resection with right hepatic vein transection, preserving the inferior right hepatic vein and segment S6. Relying on meticulous anatomical landmarks without intraoperative ultrasound, this approach offers a precise and parenchyma-sparing option for dorsally located right-liver tumors, particularly in settings with limited advanced navigation resources.
18:47
Surgical Procedures for a Rat Model of Partial Orthotopic Liver Transplantation with Hepatic Arterial Reconstruction
0 Views •
Cited by 22 •
2013
Orthotopic liver transplantation in rats is an indispensable experimental model for biomedical research. Here we present our surgical procedures for orthotopic rat liver transplantation with hepatic arterial reconstruction using a 50% partial graft.
11:24
Intrasplenic Transplantation of Hepatocytes After Partial Hepatectomy in NOD.SCID Mice
0 Views •
Cited by 1 •
2018
We have described a protocol for performing partial hepatectomy (PHx) and cell transplantation via spleen in NOD.SCID (NOD.CB17-Prkdcscid/J) mice. In this protocol, an incision is made to expose and resect the left lobe of the liver followed by another incision for the intrasplenic transplantation of cells.
07:26
Formation of Ordered Biomolecular Structures by the Self-assembly of Short Peptides
0 Views •
Cited by 6 •
2013
This paper describes the formation of highly ordered peptide-based structures by the spontaneous process of self-assembly. The method utilizes commercially available peptides and common lab equipment. This technique can be applied to a large variety of peptides and may lead to the discovery of new peptide-based assemblies.
05:56
Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
0 Views •
Cited by 1 •
2022
The present protocol uses a biomolecular simulation package and describes the molecular dynamics (MD) approach for modeling the wild-type caspase and its mutant forms. The MD method allows for assessing the dynamic evolution of the caspase structure and the potential effect of mutations or post-translational modifications.
FAQs
Pyridoxal phosphate functions as the required cofactor that enables ALT to transfer an amino group between alanine and alpha-ketoglutarate. This supports formation of pyruvate and glutamate during the reversible reaction. Because the enzyme depends on this cofactor for its normal biochemical activity, the reaction links amino-acid metabolism with the laboratory measurement used to assess liver cell injury.
Hepatocytes contain abundant ALT, so injury to these cells can release the enzyme into the bloodstream. The measured concentration therefore reflects leakage associated with cellular damage rather than a direct measurement of liver function as a whole. This mechanism explains why hepatitis, fatty liver disease, and medication-related injury may be accompanied by increased results.
ALT connects alanine metabolism with the production of pyruvate and glutamate by transferring an amino group to alpha-ketoglutarate. Because the reaction is reversible, its direction depends on the participating substrates and products. In the clinical setting, however, the importance of this chemistry is that hepatocyte injury can increase the amount of this enzyme detectable in blood.
An ALT result supports clinical assessment but does not provide a complete interpretation by itself. Clinicians consider the value together with symptoms, medical history, and other laboratory findings. This broader evaluation helps place an elevated concentration in context, including possible hepatitis, fatty liver disease, or medication-related liver injury, without treating the test as a standalone diagnosis.
ALT testing is useful when clinicians are evaluating possible liver cell injury or following a known or suspected liver-related condition. It can contribute to assessment in hepatitis, fatty liver disease, and medication-related injury. The test also supports monitoring over time, with interpretation guided by the patient’s clinical information and accompanying laboratory results.
Repeated ALT measurements can support monitoring by showing whether blood concentrations remain elevated during clinical follow-up. The result is most informative when considered alongside symptoms, medical history, and other laboratory findings. This approach allows clinicians to evaluate the significance of changes in the enzyme concentration while investigating or following conditions associated with liver cell injury.